U.S. Life Sciences Stock News

Nexstar Media Group, Inc. has already reported Q4 and full-year 2025 results, with Q4 sales of US$1,289 million versus US$1,488 million a year earlier and a Q4 net loss of US$166 million compared with prior net income of US$241 million, while full-year 2025 sales fell to US$4.95 billion and net income to US$109 million. Despite weaker year-on-year figures, the company surpassed analyst expectations for Q4 earnings and revenue, trimmed losses at The CW, and reaffirmed plans to close its...

Pagaya Technologies (NasdaqCM:PGY) is shifting its business model toward an asset-light AI infrastructure approach. The company is pivoting away from riskier segments and focusing on partnering with major banks and fintechs. Its technology is being used in areas such as prime loans and buy now, pay later services with established financial institutions. Pagaya sits at the intersection of finance and data science, providing AI-driven infrastructure that helps banks and consumer finance...

Arcutis Biotherapeutics (ARQT) is back in focus after a cluster of company updates, including first patient dosing in a Phase 1a/1b study of ARQ-234 for atopic dermatitis and fresh financial guidance. See our latest analysis for Arcutis Biotherapeutics. Despite a 1-day share price return showing an 8.19% decline and a 90-day share price return showing a 15.87% decline to US$24.76, Arcutis Biotherapeutics still shows a 1-year total shareholder return of 92.99% and a 3-year total shareholder...

Key recent performance signals for Datavault AI Datavault AI (DVLT) has been drawing attention after a difficult past 3 months, with a return of about a 64% decline, while the share price most recently closed at US$0.68. Over the past month the stock shows a small positive return, in contrast with weaker year-to-date and 1-year total returns. This may prompt investors to reassess how they view Datavault AI at current levels. At the business level, Datavault AI reports revenue of US$6.17...

OneSpaWorld Holdings reported past fourth-quarter 2025 revenue of US$242.13 million, up from US$217.21 million a year earlier, while quarterly net income eased to US$12.06 million and long-lived asset impairment charges rose to US$2.97 million. Despite slightly lower profitability, the company reaffirmed its 2026 revenue outlook, maintained a quarterly US$0.05 dividend, and completed a US$37.5 million share repurchase, signaling continued commitment to returning cash to shareholders. Against...

If you are wondering whether Badger Meter is still worth a place on your watchlist after its recent swings, the key question is how its current share price lines up against underlying value. The stock closed at US$152.20 most recently, with returns of 3.8% over 30 days, a 2.6% decline over 7 days, and longer term moves of a 13.7% decline year to date, a 26.8% decline over 1 year, 29.9% over 3 years, and 57.3% over 5 years that may leave investors reassessing risk and return. Recent coverage...

In February 2026, Allegion reported fourth quarter 2025 results showing higher year-over-year sales and net income, and issued full-year 2026 guidance calling for 5% to 7% reported revenue growth, 2% to 4% organic revenue growth, and reported EPS of US$8.00 to US$8.20 (US$8.70 to US$8.90 adjusted). The combination of continued revenue and earnings growth in 2025 alongside higher projected adjusted EPS for 2026 highlights how Allegion is leaning on its mix of security products and solutions...

Quarterly earnings beat sets fresh context for Atkore (ATKR) Atkore (ATKR) recently reported quarterly results that came in ahead of analyst expectations for both earnings per share and EBITDA, with revenue of US$655.5 million modestly above forecasts and roughly in line with last year. See our latest analysis for Atkore. The share price has been relatively muted around US$65.41, with a 1 day share price return of 1.08% and a 1 year total shareholder return of 13.38%. However, the 3 year...

If you are wondering whether Jazz Pharmaceuticals at around US$190 a share is priced attractively or already baking in a lot of expectations, you are in the right place. The stock has shown strong momentum recently, with returns of 9.9% over 7 days, 15.8% over 30 days, 10.0% year to date and 35.8% over the last year, on top of 33.4% and 18.0% over the past 3 and 5 years respectively. Recent news around Jazz Pharmaceuticals has focused on the company as a specialty pharma player and its...

Ryerson Holding Corporation recently reported fourth-quarter 2025 sales of US$1,104.8 million and a net loss of US$37.9 million, alongside full-year 2025 sales of US$4,571.3 million and a net loss of US$56.4 million, all compared with the prior year. Despite relatively steady annual sales, the company’s loss per share from continuing operations widened materially for both the quarter and full year, while it also completed a share repurchase program that retired 5,847,014 shares since its...

Cushman & Wakefield (NYSE:CWK) is expanding in Florida by adding brokerage and valuation teams to grow its presence in key regional markets. The company has launched an AI Impact Barometer to help clients assess how artificial intelligence affects real estate and the broader built environment. Cushman & Wakefield is a global commercial real estate services firm, and Florida is a major market for offices, industrial properties, housing and logistics. By bringing in new brokerage and...

On February 26, 2026, Graphic Packaging Holding amended its Fifth Amended and Restated Credit Agreement, temporarily lifting its maximum leverage covenant to as high as 5.00 to 1.00, while also adding a higher pricing tier, capping annual share repurchases at US$65,000,000, and tightening acquisition and investment limits through late 2027. Alongside this balance sheet adjustment, the board affirmed a quarterly cash dividend of US$0.11 per share, signaling an ongoing commitment to returning...

Wayfair co founder Steven Conine recently sold shares of NYSE:W. The company plans to open its second large format retail store in Atlanta as part of its expansion into physical locations. Wayfair also outlined plans to increase its use of AI technology to improve operations. Wayfair, trading at $73.77, has had mixed share performance, with a 30.8% decline year to date alongside a 101.4% gain over the past year. The stock is also down 28.7% over the past 30 days, which may shape how...

Genco Shipping & Trading (GNK) shares were in focus after the company released fourth quarter 2025 results, reporting higher quarterly revenue and net income. The company also reported a full year net loss and declared a cash dividend. See our latest analysis for Genco Shipping & Trading. Genco Shipping & Trading’s recent earnings and dividend update comes after a strong run in the market, with a 30 day share price return of 16.99% and a 1 year total shareholder return of 84.56%. This...

If you are wondering whether Summit Therapeutics is priced attractively or already expensive, you will want to understand how its current share price compares with different measures of underlying value. The stock recently closed at US$16.19, with returns of 0.6% over 7 days, 11.8% over 30 days, a 7.6% decline year to date, a 15.4% decline over 1 year, and a very large gain over 3 years and 189.1% over 5 years. Taken together, these figures point to a mix of past momentum and more recent...

Americold Realty Trust (NYSE:COLD) has agreed to acquire a temperature controlled facility in Houston, expanding its global footprint. The deal adds capacity in a key logistics hub that serves both domestic and international food supply chains. The company is integrating new technology across its network while working through operational challenges tied to customer contracts and concentration. Americold Realty Trust, listed as NYSE:COLD, focuses on temperature controlled warehouses and...

If you are trying to work out whether Full Truck Alliance is attractively priced or not, its current valuation metrics and what sits behind them are going to be the key things to focus on. The share price, last closing at US$9.32, has seen a 1.4% decline over the past week and is also down 5.9% over 30 days and 17.2% year to date, while the 3 year return sits at 17.2%. Recent news coverage has focused on Full Truck Alliance as a major digital freight platform in China and how it fits into...

Li Auto rolled out a major over the air update to its vehicle fleet ahead of the Chinese Spring Festival, upgrading its smart cockpit, VLA Driver large model, and smart electric features. The company supported more than 1.45 million charging sessions during the festival travel season through its charging network. Li Auto plans to launch a new Li L9 model in the coming quarter, adding to its flagship range. For investors tracking NasdaqGS:LI, these product and infrastructure updates come...

If you are wondering whether Grindr's current share price offers value or risk at this point, you are not alone. This article is designed to tackle that question head on. Grindr's stock closed at US$11.51, with recent returns of 2.2% over 7 days and 1.7% over 30 days, while year to date it shows a 13.5% decline and a 38.1% decline over the past year. This compares with a 59.6% return over 3 years and 13.4% over 5 years. Recent coverage has focused on Grindr's position as a publicly listed...

If you are wondering whether CDW is priced attractively today, it helps to step back and separate the share price story from the underlying value story. CDW closed at US$124.77, with a 1.3% gain over the last 7 days, a 1.3% decline over 30 days, a 6.3% decline year to date, and a 26.5% decline over the past year. The 3 and 5 year returns sit at 36.0% and 14.4% declines respectively. These moves have kept CDW on many investors' watchlists as they reassess how much risk they are taking on at...

Wave Life Sciences reported positive proof of concept for obesity candidate WVE-007 in Phase I, with fat loss and preservation of muscle mass. The company is preparing a pivotal Phase II trial for WVE-007 following these early clinical results. RNA editing candidates WVE-006 for alpha-1 antitrypsin deficiency and WVE-008 for liver disease are progressing toward key regulatory milestones. For investors tracking NasdaqGM:WVE, these updates come with a share price of $13.85 and a very large 3...

If you are wondering whether Hercules Capital is attractively priced or not, this article will walk through the numbers so you can judge the value story for yourself. The stock last closed at US$14.60, with returns of a 3.2% decline over 7 days, 21.2% decline over 30 days, 22.6% decline year to date, 20.8% decline over 1 year, 31.0% over 3 years and 63.4% over 5 years that may be catching investors' attention. Recent coverage of Hercules Capital has focused on the share price pullback and...

If you are wondering whether Middlesex Water at around US$54.55 is a bargain or just fairly priced, you are not alone, many investors are asking the same question. The stock has been fairly quiet over the last week with a 0.5% decline, but the 4.1% move over 30 days and 8.5% return year to date contrast with a 3.5% decline over 1 year and deeper 21.8% and 16.4% declines over 3 and 5 years. Recent attention on regulated utilities and their capital needs has kept investor focus on balance...

Why Douglas Dynamics (PLOW) is back on investors' radar Douglas Dynamics (PLOW) has drawn fresh attention after reporting fourth quarter 2025 earnings, issuing net sales guidance for 2026 between US$710 million and US$760 million, and affirming its quarterly dividend. See our latest analysis for Douglas Dynamics. The latest earnings release, 2026 net sales guidance and dividend affirmation come after a strong run in the shares, with a 30 day share price return of 24.44% and a 1 year total...